Wainer Andrea F 4
4 · ABBOTT LABORATORIES · Filed Feb 27, 2024
Insider Transaction Report
Form 4
Wainer Andrea F
EXECUTIVE VICE PRESIDENT
Transactions
- Exercise/Conversion
Common shares without par value
2024-02-23$59.94/sh+12,500$749,250→ 91,204 total - Sale
Common shares without par value
2024-02-23$120.00/sh−12,500$1,500,000→ 78,704 total - Exercise/Conversion
Option (right to buy)
2024-02-23−12,500→ 34,449 totalExercise: $59.94From: 2021-02-16Exp: 2028-02-15→ Common Shares (12,500 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.